MacroGenics
MGNX
#9182
Rank
A$0.16 B
Marketcap
A$2.62
Share price
-2.23%
Change (1 day)
-48.91%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: A$0.16 Billion

As of January 2026 MacroGenics has a market cap of A$0.16 Billion. This makes MacroGenics the world's 9182th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.16 B8.82%
2025A$0.15 B-53.35%
2024A$0.32 B-62.79%
2023A$0.87 B44.49%
2022A$0.60 B-55.34%
2021A$1.35 B-18.83%
2020A$1.67 B

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of MacroGenics was reported to be:

A$0.16 Billion
by Nasdaq info icon info icon
A$0.16 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Xencor
XNCR
A$1.48 B 799.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$213.73 B 129,071.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$404.18 B 244,167.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$225.82 B 136,374.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$261.01 B 157,646.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.443 T 872,197.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$170.15 B 102,733.61%๐Ÿ‡บ๐Ÿ‡ธ USA